<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03635528</url>
  </required_header>
  <id_info>
    <org_study_id>CR-6008</org_study_id>
    <nct_id>NCT03635528</nct_id>
  </id_info>
  <brief_title>Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control</brief_title>
  <official_title>Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a bilateral, non-dispensing, randomized, controlled, double-masked, 7x7 cross-over&#xD;
      study. Each subject will be bilaterally fitted with one of the 7 test articles in each of the&#xD;
      7 periods for a total of four visits. Up to two lens types will be fit at each of the four&#xD;
      study visits.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 29, 2018</start_date>
  <completion_date type="Actual">July 18, 2019</completion_date>
  <primary_completion_date type="Actual">July 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>On-Axis Accommodative Response Method 1</measure>
    <time_frame>10 minutes post-lens insertion</time_frame>
    <description>On-axis accommodative response with target vergence of 0.25D, 1D, 2D, 3D and 4D measured with a wavefront aberrometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>On-Axis Accommodative Response Method 2</measure>
    <time_frame>10 minutes post lens insertion</time_frame>
    <description>On-axis accommodative response with target vergence of 0.25D, 1D, 2D, 3D and 4D measured with an open-field auto refractor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Off-Axis Wavefront Aberrations with Accomodation</measure>
    <time_frame>10 minutes post-lens insertion</time_frame>
    <description>Off-axis wavefront aberrations at ±10°, ±20°, ±30° retinal eccentricities with targets at 4 meters will be measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Off-Axis Wavefront Aberrations without Accomodation</measure>
    <time_frame>10 minutes post lens insertion</time_frame>
    <description>Off-axis wavefront aberrations at ±30° retinal eccentricities with targets at 25 cm will be measured.</description>
  </secondary_outcome>
  <number_of_arms>14</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects between the ages of 7 and 25 years will be randomly assigned to one of fourteen unique sequences of the seven lens types.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 1</intervention_name>
    <description>EMO-114</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 2</intervention_name>
    <description>EMO-116</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 3</intervention_name>
    <description>EMO-118</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 4</intervention_name>
    <description>RMY-100</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 5</intervention_name>
    <description>Biofinity multifocal D Lens</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control Lens 1</intervention_name>
    <description>EMO-117</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control Lens 2</intervention_name>
    <description>Proclear 1 day</description>
    <arm_group_label>Control 1\Control 2\Test 5\Test 1\Test 4\Test 2\Test 3</arm_group_label>
    <arm_group_label>Control 1\Test 5\Control 2\Test 4\Test 1\Test 3\Test 2</arm_group_label>
    <arm_group_label>Control 2\Control 1\Test 1\Test 5\Test 2\Test 4\Test 3</arm_group_label>
    <arm_group_label>Control 2\Test 1\Control 1\Test 2\Test 5\Test 3\Test 4</arm_group_label>
    <arm_group_label>Test 1\Control 2\Test 2\Control 1\Test 3\Test 5\Test 4</arm_group_label>
    <arm_group_label>Test 1\Test 2\Control 2\Test 3\Control 1\Test 4\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 1\Test 3\Control 2\Test 4\Control 1\Test 5</arm_group_label>
    <arm_group_label>Test 2\Test 3\Test 1\Test 4\Control 2\Test 5\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 2\Test 4\Test 1\Test 5\Control 2\Control 1</arm_group_label>
    <arm_group_label>Test 3\Test 4\Test 2\Test 5\Test 1\Control 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 3\Test 5\Test 2\Control 1\Test 1\Control 2</arm_group_label>
    <arm_group_label>Test 4\Test 5\Test 3\Control 1\Test 2\Control 2\Test 1</arm_group_label>
    <arm_group_label>Test 5\Control 1\Test 4\Control 2\Test 3\Test 1\Test 2</arm_group_label>
    <arm_group_label>Test 5\Test 4\Control 1\Test 3\Control 2\Test 2\Test 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Potential subjects must satisfy all following criteria to be enrolled in the study:&#xD;
&#xD;
               1. Pediatric subjects (&lt;18 years old) must read (or be read to), understand, and&#xD;
                  sign the Statement of Information and Assent and receive a fully executed copy of&#xD;
                  the form.&#xD;
&#xD;
               2. Adult subjects (≥18 years old) and parent(s) or legal guardian(s) of pediatric&#xD;
                  subjects must read, understand and sign the Statement of Informed Consent and&#xD;
                  receive a fully executed copy of the form.&#xD;
&#xD;
               3. Appear able and willing to adhere to the instructions set forth in this clinical&#xD;
                  protocol.&#xD;
&#xD;
               4. Between 7 and 25 years of age (inclusive).&#xD;
&#xD;
               5. Have normal eyes (i.e., no ocular medications or infections of any type).&#xD;
&#xD;
               6. Vertex-corrected distance subjective best-sphere refraction must be between&#xD;
                  -0.75D and -5.00D (inclusive) in each eye.&#xD;
&#xD;
               7. Cylindrical refraction must be 1.00D or less in each eye, by subjective&#xD;
                  sphero-cylindrical refraction.&#xD;
&#xD;
               8. Have sphero-cylindrical best-corrected visual acuity of 20/25 or better in each&#xD;
                  eye.&#xD;
&#xD;
                  Exclusion Criteria:&#xD;
&#xD;
          -  Potential subjects who meet any of the following criteria will be excluded from&#xD;
             participating in the study:&#xD;
&#xD;
               1. Currently pregnant or lactating.&#xD;
&#xD;
               2. Any systemic allergies, infectious disease (e.g., hepatitis, tuberculosis, HIV),&#xD;
                  autoimmune disease (e.g., rheumatoid arthritis), or other diseases, by&#xD;
                  self-report, which are known to interfere with contact lens wear and/or&#xD;
                  participation in the study.&#xD;
&#xD;
               3. Use of systemic medications (e.g., chronic steroid use) that are known to&#xD;
                  interfere with contact lens wear and/or participation in the study. Specifically,&#xD;
                  any chronic (3 months or more) or short-term (within 7 days from enrollment) use&#xD;
                  of oral agents with antimuscarinic properties.&#xD;
&#xD;
               4. Any current use of ocular topical medication (occasional use of re-wetting drops&#xD;
                  is allowed). Specifically, any use of topical agents with anti-muscarinic&#xD;
                  properties within 21 days from enrollment.&#xD;
&#xD;
               5. Any previous or planned ocular or intraocular surgery, including refractive&#xD;
                  surgery.&#xD;
&#xD;
               6. Participation in any contact lens or lens care product clinical trial within 7&#xD;
                  days prior to study enrollment.&#xD;
&#xD;
               7. Current or recent (within 30 days from enrollment) rigid lens wearers.&#xD;
&#xD;
               8. History of orthokeratology treatment.&#xD;
&#xD;
               9. Any known hypersensitivity or allergic reaction to EyeCept® (or sponsor approved&#xD;
                  equivalent) Rewetting Drop Solution.&#xD;
&#xD;
              10. Employees or their children/relatives of investigational clinic (e.g.,&#xD;
                  Investigator, Coordinator, Technician).&#xD;
&#xD;
              11. Any ocular allergies, infections or other ocular abnormalities that are known to&#xD;
                  interfere with contact lens wear and/or participation in the study. This may&#xD;
                  include, but not be limited to, aphakia, uveitis, ocular hypertension, glaucoma,&#xD;
                  severe keratoconjunctivitis sicca, history of recurrent corneal erosions,&#xD;
                  keratoconus, keratoconus suspect, pellucid marginal degeneration, entropion,&#xD;
                  ectropion, extrusions, chalazia, and recurrent styes.&#xD;
&#xD;
              12. Any Grade 3 or greater slit lamp findings (eg, edema, corneal neovascularization,&#xD;
                  corneal staining, tarsal abnormalities, and conjunctival injection) on the FDA&#xD;
                  scale.&#xD;
&#xD;
              13. Any ocular abnormality that is contraindicated contact lens wear.&#xD;
&#xD;
              14. Any corneal scar within central 5mm&#xD;
&#xD;
              15. Binocular vision abnormality, intermittent strabismus or strabismus.&#xD;
&#xD;
              16. Any corneal distortion resulting from ocular diseases or previous hard or rigid&#xD;
                  gas permeable contact lens wear.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xu Cheng</last_name>
    <role>Study Chair</role>
    <affiliation>Johnson &amp; Johnson Vision Care, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University, School of Optometry</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>August 18, 2020</last_update_submitted>
  <last_update_submitted_qc>August 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

